Corporate Information

BOARD OF DIRECTORS

WILLIAM D. YOUNG

Chairman, Biogen Idec
Venture Partner,
Clarus Ventures, LLC

GEORGE A. SCANGOS, Ph.D.

Chief Executive Officer,
Biogen Idec

ALEXANDER J. DENNER, Ph.D.

Private Investor

CAROLINE D. DORSA

Executive Vice President and Chief Financial Officer,
Public Service Enterprise Group Incorporated

NANCY L. LEAMING

Retired Chief Executive Officer and President, Tufts Health Plan

RICHARD C. MULLIGAN, Ph.D.

Mallinckrodt Professor of Genetics,
Harvard Medical School

ROBERT W. PANGIA

Chief Executive Officer,
Ivy Sports Medicine, LLC

STELIOS PAPADOPOULOS, Ph.D.

Chairman, Exelixis, Inc.

BRIAN S. POSNER

Private Investor and President,
Point Rider Group LLC

ERIC K. ROWINSKY, M.D.

Head of R&D and Chief Medical Officer,
Stemline Therapeutics, Inc.

THE HONORABLE LYNN SCHENK

Attorney, former Chief of Staff to the Governor of California and former U.S. Congresswoman

STEPHEN A. SHERWIN, M.D.

Chairman, Ceregene, Inc.

 

MANAGEMENT

GEORGE A. SCANGOS, Ph.D.

Chief Executive Officer

SUSAN H. ALEXANDER

Executive Vice President, Chief Legal Officer and Corporate Secretary

PAUL J. CLANCY

Executive Vice President, Finance and Chief Financial Officer

JOHN G. COX

Executive Vice President, Pharmaceutical Operations and Technology

KENNETH DIPIETRO

Executive Vice President,
Human Resources

STEVEN H. HOLTZMAN

Executive Vice President,
Corporate Development

TONY KINGSLEY

Executive Vice President,
Global Commercial Operations

RAY PAWLICKI

Senior Vice President and
Chief Information Officer

DOUGLAS E. WILLIAMS, Ph.D.

Executive Vice President,
Research and Development

 

SHAREHOLDER INFORMATION

Corporate Headquarters

Biogen Idec Inc.
133 Boston Post Road
Weston, MA 02493
Phone: (781) 464-2000

SEC FORM 10-K

A copy of Biogen Idec's Annual Report on Form 10-K filed with the Securities and Exchange Commission is available at www.sec.gov and upon request to:
Investor Relations Department
Biogen Idec Inc.
133 Boston Post Road
Weston, MA 02493
(781) 464-2442

Transfer Agent

For shareholder questions regarding lost stock certificates, address changes and changes of ownership or names in which the shares are held, direct inquiries to:

Computershare Trust Company NA
250 Royall Street
Canton, MA 02021
(781) 575-2879
www.computershare.com

Independent Accountants

PricewaterhouseCoopers LLP
125 High Street
Boston, MA 02110

News Releases

As a service to our shareholders and prospective investors, copies of Biogen Idec news releases issued in the last 12 months are now available almost immediately 24 hours a day, seven days a week, on the web at www.businesswire.com. Biogen Idec's news releases are usually posted within one hour of being issued and are available at no cost at www.biogenidec.com.

Market Information

Our common stock trades on The NASDAQ Global Select Market under the symbol “BIIB.” The following table shows the high and low sales price for our common stock as reported by the NASDAQ Global Select Market for each quarter in the years ended December 31, 2011 and 2010.

Common Stock Price